Hyper- and hypotension are a concern for nephrology nurses caring for patients with chronic kidney disease (CKD) receiving dialysis. This session reviews the pathophysiology of hypertension in CKD, compares current hypertension guidelines (KDIGO, ACC/AHA), and addresses the implications of the SPRINT trial on future hypertension guidelines.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 5/5/2023.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure: There are no speaker disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: The American Nephrology Nurses Association (ANNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 17499.
ANNA urges participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
Learning Outcome: Upon completion of this activity, the learner will be able to explain the latest guidelines to provide evidence-based care to patients with hypertension.